Epicrispr Biotechnologies, Inc. funding

Epicrispr Biotechnologies, Inc., a biotechnology company based in South San Francisco, CA, filed a Form D with the SEC on August 26, 2026 and reported $177M raised of a $213M offering.

Amount raised$177M

Offering size$213M

Filed with the SECAugust 26, 2026

First saleMay 4, 2018

IndustryBiotechnology

SecuritiesEquity, Options or warrants, Security to be acquired on exercise

LocationSouth San Francisco, CA

FoundedMore than 5 years ago

Entity typeCorporation

Investors so far47

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 26

Other health care rounds in California

Alpfa Medical, Inc.$80.3M · Sep 28Other Health Care BigHat Biosciences, Inc.$75.1M · Oct 26Biotechnology Caspian Therapeutics, Inc.$50M · Sep 23Biotechnology Estuary Biotherapeutics, Inc.$40.7M · Oct 16Biotechnology PFARADIGM Health, Inc.$31.1M · Sep 28Other Health Care Trellis Bioscience, Inc.$22.9M · Oct 21Biotechnology Altay Therapeutics, Inc.$15.7M · Oct 2Biotechnology Adela, Inc.$12M · Oct 19Biotechnology